Literature DB >> 10718032

Kaiser Permanente's prescription drug benefit.

S Levine1, D Campen, M Millares, A Barrueta.   

Abstract

Mesh：

Year:  2000        PMID： 10718032     DOI： 10.1377/hlthaff.19.2.185

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN： 0278-2715            Impact factor:   6.301


× No keyword cloud information.
  4 in total

Review 1.  Process-Based Treatment of Diabetes in Kaiser Permanente Southern California: How to Make Diabetes Care "Complete".

Authors:  John P Martin; Natalie Aboubechara
Journal:  Curr Diab Rep       Date:  2017-09       Impact factor: 4.810

2.  Reducing drug costs at a Veterans Affairs hospital by increasing market-share of generic fluoxetine.

Authors:  Steven K Dobscha; Lisa M Winterbottom; Leann S Snodgrass
Journal:  Community Ment Health J       Date:  2006-09-22

3.  Pharmaceutical sales representatives and patient safety.

Authors:  Donald W Light
Journal:  J Gen Intern Med       Date:  2013-11       Impact factor: 5.128

4.  Potential savings of harmonising hospital and community formularies for chronic disease medications initiated in hospital.

Authors:  Lauren Lapointe-Shaw; Hadas D Fischer; Alice Newman; Ava John-Baptiste; Geoffrey M Anderson; Paula A Rochon; Chaim M Bell
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.